FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808064984> ?p ?o ?g. }

• W2808064984 endingPage "360" @default.
• W2808064984 startingPage "353" @default.
• W2808064984 abstract "Abstract Aim Pazopanib is a multitargeted tyrosine kinase inhibitor used as a standard treatment for chemotherapy‐refractory recurrent or metastatic soft tissue sarcoma. This study aimed to evaluate the efficacy and safety of pazopanib for treatment of metastatic soft tissue sarcoma in the Asian population. Methods Fifty patients with chemotherapy‐refractory recurrent or metastatic soft tissue sarcoma, who had received pazopanib treatment between 2015 and 2016 were enrolled. We reviewed patients’ clinical characteristics and studied survival outcomes following pazopanib treatment. Results Median follow‐up was 5.7 months. Seven patients were still on pazopanib by the end of this study and the disease had progressed in the other 43 patients, leading to 23 deaths. We found that despite treatment more than half the patients experienced disease progression (56% vs 14% partial response and 30% stable disease). The median progression‐free survival and overall survival was 3.1 and 11.0 months, respectively. Multivariate analysis identified good Eastern Cooperative Oncology Group performance status (0 or 1) and occurrence of hand–foot skin reaction as independent factors associated with better outcome. Hand–foot skin reaction was 32% in our cohort and the median onset time was 4 (1.00–8.29) weeks. It had dose‐dependent effect by clinical observation. Conclusions Our study showed that the incidence rate of hand–foot skin reaction in Taiwan is higher than western population, and it is an independent predictive factor for better treatment outcomes." @default.
• W2808064984 created "2018-06-21" @default.
• W2808064984 creator A5000986526 @default.
• W2808064984 creator A5004152097 @default.
• W2808064984 creator A5027932918 @default.
• W2808064984 creator A5033188236 @default.
• W2808064984 creator A5039824713 @default.
• W2808064984 creator A5045529264 @default.
• W2808064984 creator A5048749599 @default.
• W2808064984 creator A5050473175 @default.
• W2808064984 creator A5085189346 @default.
• W2808064984 creator A5089593550 @default.
• W2808064984 date "2018-06-13" @default.
• W2808064984 modified "2023-10-17" @default.
• W2808064984 title "Hand-foot skin reaction predicts treatment outcome of pazopanib in patients with metastatic soft tissue sarcoma: A multicenter study in the Asian population" @default.
• W2808064984 cites W1493453469 @default.
• W2808064984 cites W1773663185 @default.
• W2808064984 cites W1892405924 @default.
• W2808064984 cites W1988669729 @default.
• W2808064984 cites W2010986737 @default.
• W2808064984 cites W2069406030 @default.
• W2808064984 cites W2075457174 @default.
• W2808064984 cites W2101776780 @default.
• W2808064984 cites W2107230638 @default.
• W2808064984 cites W2108045918 @default.
• W2808064984 cites W2119404465 @default.
• W2808064984 cites W2122074158 @default.
• W2808064984 cites W2131705241 @default.
• W2808064984 cites W2136344041 @default.
• W2808064984 cites W2142564546 @default.
• W2808064984 cites W2150461364 @default.
• W2808064984 cites W2167798736 @default.
• W2808064984 cites W2168742889 @default.
• W2808064984 cites W2196083955 @default.
• W2808064984 cites W2270929786 @default.
• W2808064984 cites W2294806546 @default.
• W2808064984 cites W2551773592 @default.
• W2808064984 cites W2590885177 @default.
• W2808064984 cites W2752560124 @default.
• W2808064984 doi "https://doi.org/10.1111/ajco.13029" @default.
• W2808064984 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29900662" @default.
• W2808064984 hasPublicationYear "2018" @default.
• W2808064984 type Work @default.
• W2808064984 sameAs 2808064984 @default.
• W2808064984 citedByCount "8" @default.
• W2808064984 countsByYear W28080649842018 @default.
• W2808064984 countsByYear W28080649842019 @default.
• W2808064984 countsByYear W28080649842020 @default.
• W2808064984 countsByYear W28080649842021 @default.
• W2808064984 countsByYear W28080649842022 @default.
• W2808064984 countsByYear W28080649842023 @default.
• W2808064984 crossrefType "journal-article" @default.
• W2808064984 hasAuthorship W2808064984A5000986526 @default.
• W2808064984 hasAuthorship W2808064984A5004152097 @default.
• W2808064984 hasAuthorship W2808064984A5027932918 @default.
• W2808064984 hasAuthorship W2808064984A5033188236 @default.
• W2808064984 hasAuthorship W2808064984A5039824713 @default.
• W2808064984 hasAuthorship W2808064984A5045529264 @default.
• W2808064984 hasAuthorship W2808064984A5048749599 @default.
• W2808064984 hasAuthorship W2808064984A5050473175 @default.
• W2808064984 hasAuthorship W2808064984A5085189346 @default.
• W2808064984 hasAuthorship W2808064984A5089593550 @default.
• W2808064984 hasConcept C121332964 @default.
• W2808064984 hasConcept C121608353 @default.
• W2808064984 hasConcept C126322002 @default.
• W2808064984 hasConcept C141071460 @default.
• W2808064984 hasConcept C142424586 @default.
• W2808064984 hasConcept C142724271 @default.
• W2808064984 hasConcept C143998085 @default.
• W2808064984 hasConcept C2778256501 @default.
• W2808064984 hasConcept C2778439243 @default.
• W2808064984 hasConcept C2778629024 @default.
• W2808064984 hasConcept C2778820342 @default.
• W2808064984 hasConcept C2779490328 @default.
• W2808064984 hasConcept C2908647359 @default.
• W2808064984 hasConcept C71924100 @default.
• W2808064984 hasConcept C87355193 @default.
• W2808064984 hasConcept C99454951 @default.
• W2808064984 hasConceptScore W2808064984C121332964 @default.
• W2808064984 hasConceptScore W2808064984C121608353 @default.
• W2808064984 hasConceptScore W2808064984C126322002 @default.
• W2808064984 hasConceptScore W2808064984C141071460 @default.
• W2808064984 hasConceptScore W2808064984C142424586 @default.
• W2808064984 hasConceptScore W2808064984C142724271 @default.
• W2808064984 hasConceptScore W2808064984C143998085 @default.
• W2808064984 hasConceptScore W2808064984C2778256501 @default.
• W2808064984 hasConceptScore W2808064984C2778439243 @default.
• W2808064984 hasConceptScore W2808064984C2778629024 @default.
• W2808064984 hasConceptScore W2808064984C2778820342 @default.
• W2808064984 hasConceptScore W2808064984C2779490328 @default.
• W2808064984 hasConceptScore W2808064984C2908647359 @default.
• W2808064984 hasConceptScore W2808064984C71924100 @default.
• W2808064984 hasConceptScore W2808064984C87355193 @default.
• W2808064984 hasConceptScore W2808064984C99454951 @default.
• W2808064984 hasIssue "4" @default.
• W2808064984 hasLocation W28080649841 @default.
• W2808064984 hasLocation W28080649842 @default.
• W2808064984 hasOpenAccess W2808064984 @default.

• next